company background image

Animalcare Group AIM:ANCR Stock Report

Last Price


Market Cap







01 Jul, 2022


Company Financials +
ANCR fundamental analysis
Snowflake Score
Future Growth0/6
Past Performance0/6
Financial Health6/6

ANCR Stock Overview

Animalcare Group plc engages in the development, sale, and distribution of licensed veterinary pharmaceuticals and identification products, and services for companion and production animals, and equine veterinary markets.

Animalcare Group Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Animalcare Group
Historical stock prices
Current Share PriceUK£2.67
52 Week HighUK£4.30
52 Week LowUK£2.55
1 Month Change-11.74%
3 Month Change-20.30%
1 Year Change-24.15%
3 Year Change68.45%
5 Year Changen/a
Change since IPO-25.83%

Recent News & Updates

Jun 21
Is There An Opportunity With Animalcare Group plc's (LON:ANCR) 20% Undervaluation?

Is There An Opportunity With Animalcare Group plc's (LON:ANCR) 20% Undervaluation?

Does the June share price for Animalcare Group plc ( LON:ANCR ) reflect what it's really worth? Today, we will estimate...

Shareholder Returns

ANCRGB PharmaceuticalsGB Market

Return vs Industry: ANCR underperformed the UK Pharmaceuticals industry which returned 18.8% over the past year.

Return vs Market: ANCR underperformed the UK Market which returned -9.5% over the past year.

Price Volatility

Is ANCR's price volatile compared to industry and market?
ANCR volatility
ANCR Average Weekly Movement2.5%
Pharmaceuticals Industry Average Movement5.5%
Market Average Movement5.4%
10% most volatile stocks in GB Market10.6%
10% least volatile stocks in GB Market2.8%

Stable Share Price: ANCR is less volatile than 75% of UK stocks over the past 3 months, typically moving +/- 3% a week.

Volatility Over Time: ANCR's weekly volatility (3%) has been stable over the past year.

About the Company

1972211Jenny Winters

Animalcare Group plc engages in the development, sale, and distribution of licensed veterinary pharmaceuticals and identification products, and services for companion and production animals, and equine veterinary markets. It is also involved in the wholesale and marketing of veterinary pharmaceuticals. The company serves customers in Belgium, the Netherlands, the United Kingdom, Germany, Spain, Italy, Portugal, other European countries, Asia, the Middle East, Africa, and internationally.

Animalcare Group Fundamentals Summary

How do Animalcare Group's earnings and revenue compare to its market cap?
ANCR fundamental statistics
Market CapUK£160.45m
Earnings (TTM)-UK£77.00k
Revenue (TTM)UK£74.02m


P/S Ratio


P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
ANCR income statement (TTM)
Cost of RevenueUK£34.61m
Gross ProfitUK£39.42m
Other ExpensesUK£39.50m

Last Reported Earnings

Dec 31, 2021

Next Earnings Date


Earnings per share (EPS)-0.0013
Gross Margin53.25%
Net Profit Margin-0.10%
Debt/Equity Ratio11.7%

How did ANCR perform over the long term?

See historical performance and comparison



Current Dividend Yield


Payout Ratio
We’ve recently updated our valuation analysis.


Is ANCR undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score


Valuation Score 5/6

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • PEG Ratio

Key Valuation Metric

Which metric is best to use when looking at relative valuation for ANCR?

Other financial metrics that can be useful for relative valuation.

ANCR key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue2.2x
Enterprise Value/EBITDA16x
PEG Ration/a

Price to Sales Ratio vs Peers

How does ANCR's PS Ratio compare to its peers?

ANCR PS Ratio vs Peers
The above table shows the PS ratio for ANCR vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPSEstimated GrowthMarket Cap
Peer Average4.3x
AGY Allergy Therapeutics
EAH ECO Animal Health Group
APH Alliance Pharma
STX Shield Therapeutics
ANCR Animalcare Group

Price-To-Sales vs Peers: ANCR is good value based on its Price-To-Sales Ratio (2.2x) compared to the peer average (4.3x).

Price to Earnings Ratio vs Industry

How does ANCR's PE Ratio compare vs other companies in the GB Pharmaceuticals Industry?

Price-To-Sales vs Industry: ANCR is good value based on its Price-To-Sales Ratio (2.2x) compared to the UK Pharmaceuticals industry average (4.9x)

Price to Sales Ratio vs Fair Ratio

What is ANCR's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

ANCR PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio2.2x
Fair PS Ratio3.4x

Price-To-Sales vs Fair Ratio: ANCR is good value based on its Price-To-Sales Ratio (2.2x) compared to the estimated Fair Price-To-Sales Ratio (3.4x).

Share Price vs Fair Value

What is the Fair Price of ANCR when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: ANCR (£2.67) is trading below our estimate of fair value (£3.46)

Significantly Below Fair Value: ANCR is trading below fair value by more than 20%.

Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate ANCR's PEG Ratio to determine if it is good value.

Discover undervalued companies

Future Growth

How is Animalcare Group forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?

Future Growth Score


Future Growth Score 0/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


Forecasted annual revenue growth

Earnings and Revenue Growth Forecasts

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if ANCR's forecast earnings growth is above the savings rate (0.9%).

Earnings vs Market: Insufficient data to determine if ANCR's earnings are forecast to grow faster than the UK market

High Growth Earnings: Insufficient data to determine if ANCR's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: ANCR's revenue (3.2% per year) is forecast to grow slower than the UK market (4.1% per year).

High Growth Revenue: ANCR's revenue (3.2% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if ANCR's Return on Equity is forecast to be high in 3 years time

Discover growth companies

Past Performance

How has Animalcare Group performed over the past 5 years?

Past Performance Score


Past Performance Score 0/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: ANCR is currently unprofitable.

Growing Profit Margin: ANCR is currently unprofitable.

Past Earnings Growth Analysis

Earnings Trend: ANCR is unprofitable, and losses have increased over the past 5 years at a rate of 25.8% per year.

Accelerating Growth: Unable to compare ANCR's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: ANCR is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (2.2%).

Return on Equity

High ROE: ANCR has a negative Return on Equity (-0.097%), as it is currently unprofitable.

Discover strong past performing companies

Financial Health

How is Animalcare Group's financial position?

Financial Health Score


Financial Health Score 6/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Stable Cash Runway

  • Forecast Cash Runway

Financial Position Analysis

Short Term Liabilities: ANCR's short term assets (£24.3M) exceed its short term liabilities (£14.5M).

Long Term Liabilities: ANCR's short term assets (£24.3M) exceed its long term liabilities (£16.8M).

Debt to Equity History and Analysis

Debt Level: ANCR's net debt to equity ratio (4.6%) is considered satisfactory.

Reducing Debt: ANCR's debt to equity ratio has reduced from 123.5% to 11.7% over the past 5 years.

Balance Sheet

Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: Whilst unprofitable ANCR has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.

Forecast Cash Runway: ANCR is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 36.1% per year.

Discover healthy companies


What is Animalcare Group current dividend yield, its reliability and sustainability?

Dividend Score


Dividend Score 1/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Future Dividend Coverage


Current Dividend Yield

Dividend Yield vs Market

Notable Dividend: ANCR's dividend (1.8%) isn’t notable compared to the bottom 25% of dividend payers in the UK market (1.91%).

High Dividend: ANCR's dividend (1.8%) is low compared to the top 25% of dividend payers in the UK market (5.28%).

Stability and Growth of Payments

Stable Dividend: ANCR has been paying a dividend for less than 10 years and during this time payments have been volatile.

Growing Dividend: ANCR's dividend payments have increased, but the company has only paid a dividend for 4 years.

Earnings Payout to Shareholders

Earnings Coverage: ANCR is paying a dividend but the company is unprofitable.

Cash Payout to Shareholders

Cash Flow Coverage: With its reasonably low cash payout ratio (26.7%), ANCR's dividend payments are well covered by cash flows.

Discover strong dividend paying companies


How experienced are the management team and are they aligned to shareholders interests?


Average management tenure


Jenny Winters (62 yo)





Ms. Jennifer Ann Julia Winters, also known as Jenny, BSc, serves as an Independent Non-Executive Director at EKF Diagnostics Holdings plc since February 1, 2022. She serves as Chief Executive Officer at An...

CEO Compensation Analysis

Compensation vs Market: Jenny's total compensation ($USD569.02K) is about average for companies of similar size in the UK market ($USD696.27K).

Compensation vs Earnings: Jenny's compensation has increased whilst the company is unprofitable.

Leadership Team

Experienced Management: ANCR's management team is considered experienced (4.9 years average tenure).

Board Members

Experienced Board: ANCR's board of directors are considered experienced (4.9 years average tenure).


Who are the major shareholders and have insiders been buying or selling?

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Company Information

Animalcare Group plc's employee growth, exchange listings and data sources

Key Information

  • Name: Animalcare Group plc
  • Ticker: ANCR
  • Exchange: AIM
  • Founded: 1972
  • Industry: Pharmaceuticals
  • Sector: Pharmaceuticals & Biotech
  • Implied Market Cap: UK£160.446m
  • Shares outstanding: 60.09m
  • Website:

Number of Employees


  • Animalcare Group plc
  • Unit 7, York Business Park
  • 10 Great North Way
  • York
  • North Yorkshire
  • YO26 6RB
  • United Kingdom


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/07/01 00:00
End of Day Share Price2022/07/01 00:00
Annual Earnings2021/12/31

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.